J1631Haloperidol decanoate inj
Published CMS Medicare Part B payment-limit context for J1631, with recent quarterly history and calculated package-level strength context from the CMS crosswalk.
CMS payment limit
$5.291
per 50 MG · Medicare Part B
Down 12.8%from $6.07 in 2026-Q2
- Current quarter
- Billing unit
Payment limit over time
$7.1789$3.5411
2024-Q4: $6.781; 2025-Q1: $5.547; 2025-Q2: $4.611; 2025-Q3: $4.682; 2025-Q4: $4.401; 2026-Q1: $3.939; 2026-Q2: $6.07; 2026-Q3: $5.291
No current FDA shortage matchThe latest completed FDA data has no affected record matching the Haloperidol Decanoate ingredient family (FDA data as of August 20, 2026).
Haloperidol Decanoate
Package figures are calculated from the CMS per-unit payment limit × billable units per package; they are not CMS-published package-level payment limits.
Put another code on your radar.
Browse the CMS directory for published payment-limit context across drugs, NDCs, and source-backed HCPCS Level II drug codes.